secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001683168-23-005405
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign Q2 revenue up 28% to $11.0M; Adjusted EBITDA $1.1M; guides FY rev $44-46M
--------------------------------------------------------------------------------

- Revenue $11.0M, up 28% YoY; net loss $0.1M ($0.00 EPS).
- Adjusted EBITDA $1.1M, up 23% YoY; FY 2023 guidance revenue $44-46M, Adj EBITDA $6.0-7.5M.
- Added 4 net plasma centers, exit at 443; launched 5 new patient affordability programs, now 31 active.
- Pharma patient affordability revenue up 133% to $729K; repurchased 119,558 shares for $312K.
- Transitioned 16 mature plasma centers in July, total >460 centers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316823005405/0001683168-23-005405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316823005405/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-005405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer